Our CEO, Dr. Richard Thompson, has done it again! Rick’s been published alongside his co-author Tom Lynam, who is Head of Marketing at Arkivum, in pharmaphorum!
Rick and Tom discuss the use of AI and technology to unlock new treatments for rare diseases and how information from clinical trials should be accessible in order to achieve this.
Read their article on drug repurposing, AI and rare disease below now!